ConductScience.org, home

Paper9749485

Comparing treatments for localized prostate cancer--persisting uncertainty.

Chodak GW. JAMA, 1998. Cited by 33 papers, by iCite.

Cite this record

ConductScience Library. Comparing treatments for localized prostate cancer--persisting uncertainty. Papers, record 9749485. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9749485

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Comparing treatments for localized prostate cancer--persisting uncertainty.
PubMed
Journal
JAMA
PubMed
Year
1998
PubMed
Publication types
Comment, Editorial
PubMed
Citations, by iCite
33
iCite
Relative citation ratio, by iCite
1.2
iCite
Revised in PubMed
2019-07-01
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chodak GWG W

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Prostatic NeoplasmsMajor topic
Humans
Male
Risk Factors
Survival Analysis

Comments and corrections3

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment in10235145Prostatectomy, external beam radiation therapy, or brachytherapy for localized prostate cancer.https://conductscience.org/library/papers/10235145PubMed
Comment on9749478Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.https://conductscience.org/library/papers/9749478PubMed
Comment on9749479Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer.https://conductscience.org/library/papers/9749479PubMed

Download CSV of comments and corrections

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.

PMIDTitleJournalYearIn PapersSource
26587019Reduced Cardiovascular Capacity and Resting Metabolic Rate in Men with Prostate Cancer Undergoing Androgen Deprivation: A Comprehensive Cross-Sectional Investigation.Adv Urol2015https://conductscience.org/library/papers/26587019PubMed
22898989Patients with prostate cancer treated by ADT have significantly higher fibrinogenemia than healthy control.World J Urol2013https://conductscience.org/library/papers/22898989PubMed
19563641A phase III clinical trial of exercise modalities on treatment side-effects in men receiving therapy for prostate cancer.BMC Cancer2009https://conductscience.org/library/papers/19563641PubMed
17486110Exercise can prevent and even reverse adverse effects of androgen suppression treatment in men with prostate cancer.Prostate Cancer Prostatic Dis2007https://conductscience.org/library/papers/17486110PubMed
15117386Agreement between prostate cancer patients and their clinicians about utilities and attribute importance.Health Expect2004https://conductscience.org/library/papers/15117386PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9749485

GET https://conductscience.org/api/papers/v1/9749485/authors